Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.
Journal: The Lancet. Oncology
Published: December 02, 2017
Imaging in Advanced Non-Small Cell Lung Cancer: A Medical Oncology Perspective.
Journal: Journal of thoracic imaging
Published: June 17, 2016
Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinib.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 20, 2014
Biomarkers in the selection of maintenance therapy in non-small cell lung cancer.
Journal: Translational lung cancer research
Published: March 01, 2012
A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with relapsed or refractory non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 17, 2003
Locally advanced esophageal cancer.
Journal: Current treatment options in oncology
Published: October 24, 2002
Showing 1-6 of 6
Last Updated: 09/26/2026